Since a small heterozygote advantage will increase the frequency of the mutant allele in the population even in carriers of severe diseases like CAH, it is not a surprise that the carrier frequency of CYP21A2 is high. This evidence concerns the gene CYP21A2 and congenital adrenal hyperplasia.